akebia therapeutics inc (AKBA:NASDAQ)
Senior VP & Chief Business Officer,Akebia Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2017
Mr. Michel Dahan has been the Chief Business Officer and Senior Vice President at Akebia Therapeutics, Inc. since October 09, 2015. Mr. Dahan served as Vice President of Business Operations at Akebia Therapeutics, Inc. until October 09, 2015. Mr. Dahan served as Vice President of Commercial at Akebia Therapeutics, Inc., since 2013. Mr. Dahan joined Akebia in 2013 and leads global marketing and commercialization activities. served as the Vice President of Commercial Development ...
245 First StreetPhone: 617-871-2098
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|William K. Heiden||CEO, President & Director|
AMAG Pharmaceuticals, Inc.
|Stuart Paul||President, CEO & Director|
Rockwell Medical, Inc.
|$484.6K||Compensation as of Fiscal Year 2018.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.